Acupuncture versus valproic acid in the prophylaxis of migraine without aura: A prospective controlled study

Minerva Anestesiologica

Volumn 79, Issue 6, 2013, Pages 634-642

  Facco, E ^a   Liguori, A ^b   Petti, F ^b   Fauci, A J ^c   Cavallin, F ^d   Zanette, G ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d NONE

Author keywords

Acupuncture; Migraine without aura; Pain; Rizatriptan; Valproic acid

Indexed keywords

AMITRIPTYLINE; CALCIUM ANTAGONIST; DEPAKIN CHRONO; PIZOTIFEN; RIZATRIPTAN; UNCLASSIFIED DRUG; VALPROIC ACID;

ABDOMINAL PAIN; ACUPUNCTURE; ADULT; ARTICLE; CONSTIPATION; DROWSINESS; FEMALE; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITHOUT AURA; NAUSEA; PAIN ASSESSMENT; PROSPECTIVE STUDY; PRURITUS; SIDE EFFECT; SOCIAL ASPECT; TREATMENT DURATION; VISUAL ANALOG SCALE; WEIGHT GAIN;

ACUPUNCTURE THERAPY; ADULT; ANTICONVULSANTS; FEMALE; HUMANS; MALE; MIGRAINE WITHOUT AURA; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SAMPLE SIZE; SEROTONIN AGENTS; TRIAZOLES; TRYPTAMINES; VALPROIC ACID;

EID: 84881402383     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Linde K, Allais G, Brinkhaus B et al.: Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev 2009;CD001218.
2. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for tension-type headache. Cochrane Database Syst Rev 2009;CD007587.
3. Allais G, De Lorenzo C, Quirico PE, Airola G, Tolardo G, Mana O et al. Acupuncture in the prophylactic treatment of migraine without aura: a comparison with flunarizine. Headache 2002;42:855-861. (Pubitemid 35285374)
4. Streng A, Linde K, Hoppe A, Pfaffenrath V, Hammes M, Wagenpfeil S et al. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophyaxis. Headache 2006;46:1492-502. (Pubitemid 44722187)
5. Wang LP, Zhang XZ, Guo J, Liu HL, Zhang Y, Liu CZ et al. Efficacy of acupuncture for migraine prophylaxis: a single-blinded, double-dummy, randomized controlled trial. Pain 2011;152:1864-71.
6. von Peter S, Ting W, Scrivani S, Korkin E, Okvat H, Gross M et al. Survey on the use of complementary and alternative medicine among patients with headache syndromes. Cephalalgia 2002;22:395-400. (Pubitemid 36613290)
7. Adelman J, Freitag FG, Lainez M, Shi Y, Ascher S, Mao L et al. Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials. Pain Med 2008;9:175-85. (Pubitemid 351285412)
8. Apostol G, Lewis DW, Laforet GA, Robieson WZ, Fugate JM, Abi-Saab WM et al. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study. Headache 2009;49:45-53.
9. Artemenko AR, Kurenkov AL, Filatova EG, Nikitin SS, Kaube H, Katsarava Z. Effects of topiramate on migraine frequency and cortical excitability in patients with frequent migraine. Cephalalgia 2008;28:203-8. (Pubitemid 351172028)
10. Bartolini M, Silvestrini M, Taffi R, Lanciotti C, Luconi R, Capecci M et al. Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol 2005;28:277-9. (Pubitemid 44378618)
11. D'Amico D. Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: a review of their efficacy and tolerability. Neurol Sci 2007;28(Suppl 2):S188-S197. (Pubitemid 46813651)
12. Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study. Headache 2006;46:642-8.
13. Schurks M, Diener HC, Goadsby P. Update on the prophylaxis of migraine. Curr Treat Options Neurol 2008;10:20-9.
14. Yang CP, Chang MH, Liu PE, Li TC, Hsieh CL, Hwang KL et al. Acupuncture versus topiramate in chronic migraine prophylaxis: a randomized clinical trial. Cephalalgia 2011;31:1510-21.
15. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D. STRICTA Revision Group. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. J Altern Complement Med 2010;16:ST1-14.
16. Penzien DB, Andrasik F, Freidenberg BM, Houle TT, Lake AE 3rd, Lipchik GL et al. Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup. Headache 2005;45(Suppl 2):S110-S132. (Pubitemid 40840362)
17. The International Classification of Headache Disorders. Second edition. Cephalalgia 2004;24(Suppl 1):9-160.
18. Facco E, Liguori A, Petti F, Zanette G, Coluzzi F, De Nardin M et al. Traditional acupuncture in migraine: a controlled, randomized study. Headache 2008;48:398-407. (Pubitemid 351517781)
19. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 1999;19:107-14. (Pubitemid 29170106)
20. Marchar DB, Harpole L, Samsa GP, Jurgelski A, Lipton RB, Silberstein SD et al. The headache management trial: a randomized study of coordinated care. Headache 2008;48:1294-310.
21. Irimia P, Palma JA, Fernandez-Torron R, Martinez-Vila E. Refractory migraine in a headache clinic population. BMC Neurol 2011:11:94.
22. Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D'Amico D. Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci 2004;25(Suppl 3):S105-S107. (Pubitemid 41461969)
23. Devers A, Galer BS: Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain 2000;16:205-.
24. D'Amico D, Mosconi P, Genco S, Usai S, Prudenzano AM, Grazzi L et al. The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia 2001;21:947-52. (Pubitemid 34626030)
25. Pradalier A, Auray JP, El Hasnaoui A, Alzahouri K, Dartigues JF, Duru G et al. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study. Pharmacoeconomics 2004;22:985-99. (Pubitemid 39472624)
26. Bigal ME, Rapoport AM, Bordini CA, Tepper SJ, Sheftell FD, Speciali JG. Burden of migraine in Brazil: estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care. Headache 2003;43:742-54. (Pubitemid 36993012)
27. Lambert J, Carides GW, Meloche JP, Gerth WC, Marentette MA. Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial. Can J Clin Pharmacol 2002;9:158-64. (Pubitemid 35408200)
28. Gerth WC, Carides GW, Dasbach EJ, Visser WH, Santanello NC. The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics 2001;19:197-206. (Pubitemid 32176472)
29. Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 2006;5:310-6.
30. Millan-Guerrero RO, Isais-Millan R, Barreto-Vizcaino S, Rivera-Castaño L, Garcia-Solorzano A, López-Bianca C et al. Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study. Eur J Neurol 2007;14:1079-84. (Pubitemid 47459724)
31. Palermo A, Fierro B, Giglia G, Cosentino G, Puma AR, Brighina F. Modulation of visual cortex excitability in migraine with aura: effects of valproate therapy. Neurosci Lett 2009;467:26-9.
32. Silberstein SD, Collins SD. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group. Headache 1999;39:633-43.
33. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. World Medical Association [Internet]. Available at 2008; http://www.wma.net/en/30publications/10policies/b3/index.html [cited 2013, Apr 15].
34. Yang ES, Li PW, Nilius B, Li G. Ancient Chinese medicine and mechanistic evidence of acupuncture physiology. Pflugers Arch 2011;462:645-53.
35. Jou NT, Ma SX. Responses of nitric oxide-cGMP release in acupuncture point to electroacupuncture in human skin in vivo using dermal microdialysis. Microcirculation 2009;16:434-43.
36. Manni L, Rocco ML, Barbaro PS, Guaragna M. Electroacupucture and nerve growth factor: potential clinical applications. Arch Ital Biol 2011;149:247-55.
37. Tsuchiya M, Sato EF, Inoue M, Asada A. Acupuncture enhances generation of nitric oxide and increases local circulation. Anesth Analg 2007;104:301-7. (Pubitemid 46146733)
38. Cabyoglu MT, Ergene N, Tan U. The mechanism of acupuncture and clinical applications. Int J Neurosci 2006;116:115-25. (Pubitemid 43067727)
39. Ceccherelli F, Facco E. Methodological problems on acupuntura research in pain therapy. In: Capasso A, editor. Recent developments in pain research. Kerala, India.: Research Signpost; 2005. p. 217-28.
40. Facco E. Acupuncture in headache: state of the art. Proceedings of the International symposium on acupuncture, World Federation of Acupuncture Societies, Rome, 2002 Nov. 7-9;p. 99-102. Rome: Paracelso; 2002.
41. Zhao CH, Stillman MJ, Rozen TD. Traditional and evidence-based acupuncture in headache management: theory, mechanism, and practice. Headache 2005;45:716-30. (Pubitemid 40798693)